216 related articles for article (PubMed ID: 29730159)
1. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
Zhang M; Kong B; Huang M; Wan R; Armstrong LE; Schumacher JD; Rizzolo D; Chow MD; Lee YH; Guo GL
Dig Liver Dis; 2018 Oct; 50(10):1068-1075. PubMed ID: 29730159
[TBL] [Abstract][Full Text] [Related]
2. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury.
Kong B; Zhang M; Huang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Guo GL
Dig Liver Dis; 2019 Apr; 51(4):570-576. PubMed ID: 30803859
[TBL] [Abstract][Full Text] [Related]
3. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR.
Li L; Xu S; Wang W; Li X; Wang H; Yang Q; Wang C; Gu J; Luo H; Meng Q
Phytomedicine; 2024 Jul; 130():155693. PubMed ID: 38763006
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
5. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
[TBL] [Abstract][Full Text] [Related]
6. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
7. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
[TBL] [Abstract][Full Text] [Related]
8. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
9. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.
Huang M; Kong B; Zhang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Joseph LB; Stofan M; Zhang L; Guo GL
Lab Invest; 2020 Sep; 100(9):1158-1168. PubMed ID: 32404932
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling.
Xiao L; Xu G; Chen S; He Y; Peng F; Yuan C
Phytomedicine; 2023 Nov; 120():155055. PubMed ID: 37678053
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease.
Liu H; Beier JI; Arteel GE; Ramsden CE; Feldstein AE; McClain CJ; Kirpich IA
Am J Pathol; 2015 Jan; 185(1):43-54. PubMed ID: 25447051
[TBL] [Abstract][Full Text] [Related]
12. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
[TBL] [Abstract][Full Text] [Related]
13. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.
Hao F; Cubero FJ; Ramadori P; Liao L; Haas U; Lambertz D; Sonntag R; Bangen JM; Gassler N; Hoss M; Streetz KL; Reissing J; Zimmermann HW; Trautwein C; Liedtke C; Nevzorova YA
Cell Death Dis; 2017 Oct; 8(10):e3152. PubMed ID: 29072704
[TBL] [Abstract][Full Text] [Related]
15. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation.
Jiang M; Li F; Liu Y; Gu Z; Zhang L; Lee J; He L; Vatsalya V; Zhang HG; Deng Z; Zhang X; Chen SY; Guo GL; Barve S; McClain CJ; Feng W
Hepatology; 2023 Apr; 77(4):1164-1180. PubMed ID: 35689610
[TBL] [Abstract][Full Text] [Related]
16. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
[TBL] [Abstract][Full Text] [Related]
17. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
[TBL] [Abstract][Full Text] [Related]
18. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.
Kong B; Zhu Y; Li G; Williams JA; Buckley K; Tawfik O; Luyendyk JP; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G295-302. PubMed ID: 26744468
[TBL] [Abstract][Full Text] [Related]
19. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
20. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]